What are the Challenges in Evaluating Nanomedicines?
Evaluating nanomedicines poses unique challenges due to their complex structures and behaviors at the nanoscale. Some of the main challenges include:
Characterization: Comprehensive characterization of nanoparticles is essential to understand their properties and behaviors in biological systems. Toxicology: Nanoparticles may exhibit different toxicological profiles compared to their bulk counterparts, necessitating thorough toxicological assessments. Regulatory Pathways: The regulatory pathways for nanomedicines can be complex, requiring collaboration between multidisciplinary teams and regulatory authorities.
